Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparitiesSikander Ailawadhi, Asher Chanan‐Khan, Vivek Roy et al.|Blood Cancer Journal|2024Cited by 8
Patient Awareness of CAR-T and Bispecific Antibody Treatments for Multiple Myeloma: Real-World Learnings and DisparitiesYaw Adu, Sikander Ailawadhi, Saurav Das et al.|Blood|2023Cited by 3
Factors Determining Utilization of Stem Cell Transplant for Initial Therapy of Multiple Myeloma by Patient Race: Exploring Intra-racial Healthcare Disparities.Sikander Ailawadhi, Asher Chanan‐Khan, Yaw Adu et al.|Research Square|2024Cited by 0
Survivorship Burden and Patient Preferences Affecting Treatment Choices Among Multiple Myeloma (MM) Patients: Real-World Learnings from a Large, Prospective StudyJayla Mondy, Sikander Ailawadhi, Saurav Das et al.|Blood|2024Cited by 0
Predicting survivorship and caregiver burden in multiple myeloma (MM) using machine learning (ML): Insights from a large, national, prospective study.Saurav Das, Sikander Ailawadhi, Jayla Mondy et al.|Journal of Clinical Oncology|2025Cited by 0